Future Science Group
Supplementary Table S1 (2).docx (14.38 kB)

Supplementary Material - Safety and effectiveness of the 300 IR sublingual house dust mite allergen immunotherapy tablet in a real-world setting: 2-year interim analysis of a specified drug-use survey

Download (14.38 kB)
posted on 2021-10-18, 12:50 authored by Yoshitaka Okamoto, Kiyonori Ishii, Moe Kato, Haruna Hayashi, Tomohisa Hata

Supplementary Table S1. Mite antigen allergy tests performed in patients per analysis set.

Data are expressed as n (%).

a Patients had been diagnosed at other hospital before entering the survey study.

CAP-RAST, ImmunoCAP Specific IgE blood test (CAP)-radioallergosorbent test (RAST); MAST-33, Multiple Antigen Simultaneous Test; View-36, Multiple (36) antigen test.